AIMS: To investigate whether Type 2 diabetic patients exhibit characteristic patterns of circadian variation in plasma levels of catecholamines, blood pressure (BP) and heart rate variability (HRV). METHODS: Ten Type 2 diabetic and eight control in-patients were studied. Blood for catecholamine measurement was collected every 4 h, and non-invasive ambulatory BP and heart rate were monitored throughout the day. HRV was determined using frequency domain methods. RESULTS: Diabetic patients showed a different pattern of circadian variation in BP and HRV from that of controls, the diurnal-nocturnal differences (D-N) being significantly smaller. The mean 24-h HRV levels were reduced in diabetic subjects. The mean 24-h plasma noradrenaline level of 1.36 +/- 0.12 nmol/l in diabetic patients was significantly lower than the 2.03 +/- 0.20 nmol/l in controls (P < 0.01). In contrast, no significant difference in adrenaline levels was observed. The mean 24-h plasma noradrenaline level demonstrated a significant positive correlation with D-N in systolic BP (r = 0.49, P = 0.0153). CONCLUSIONS: The present study demonstrated distinctive patterns of circadian variation in plasma noradrenaline level, BP and HRV in Type 2 diabetic patients, associated with an abnormal circadian pattern of sympathovagal modulation.
AIMS: To investigate whether Type 2 diabeticpatients exhibit characteristic patterns of circadian variation in plasma levels of catecholamines, blood pressure (BP) and heart rate variability (HRV). METHODS: Ten Type 2 diabetic and eight control in-patients were studied. Blood for catecholamine measurement was collected every 4 h, and non-invasive ambulatory BP and heart rate were monitored throughout the day. HRV was determined using frequency domain methods. RESULTS:Diabeticpatients showed a different pattern of circadian variation in BP and HRV from that of controls, the diurnal-nocturnal differences (D-N) being significantly smaller. The mean 24-h HRV levels were reduced in diabetic subjects. The mean 24-h plasma noradrenaline level of 1.36 +/- 0.12 nmol/l in diabeticpatients was significantly lower than the 2.03 +/- 0.20 nmol/l in controls (P < 0.01). In contrast, no significant difference in adrenaline levels was observed. The mean 24-h plasma noradrenaline level demonstrated a significant positive correlation with D-N in systolic BP (r = 0.49, P = 0.0153). CONCLUSIONS: The present study demonstrated distinctive patterns of circadian variation in plasma noradrenaline level, BP and HRV in Type 2 diabeticpatients, associated with an abnormal circadian pattern of sympathovagal modulation.
Authors: Xian Li; Michele L Shaffer; Sol Rodriguez-Colon; Fan He; Deborah L Wolbrette; Peter Alagona; Chuntao Wu; Duanping Liao Journal: Clin Auton Res Date: 2011-01-15 Impact factor: 4.435
Authors: Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong Journal: Am J Physiol Heart Circ Physiol Date: 2008-08-15 Impact factor: 4.733
Authors: Florim Cuculi; Neil Herring; Alberto R De Caterina; Adrian P Banning; Bernard D Prendergast; John C Forfar; Robin P Choudhury; Keith M Channon; Rajesh K Kharbanda Journal: Heart Date: 2013-02-12 Impact factor: 5.994
Authors: Yohannes W Endeshaw; William B White; Michael Kutner; Joseph G Ouslander; Donald L Bliwise Journal: J Gerontol A Biol Sci Med Sci Date: 2009-02-05 Impact factor: 6.053